Cyclophosphamide-induced GPX4 degradation triggers parthanatos by activating AIFM1
- 21 March 2022
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 606, 68-74
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- HMGB1 in health and diseaseMolecular Aspects of Medicine, 2014
- Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-NonenalOxidative Medicine and Cellular Longevity, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Formation of cyclophosphamide specific DNA adducts in hematological diseasesPediatric Blood & Cancer, 2011
- Apoptosis-Inducing Factor: Structure, Function, and Redox RegulationAntioxidants & Redox Signaling, 2011
- Endogenous HMGB1 regulates autophagyJournal of Cell Biology, 2010
- Activation of Poly(ADP)-ribose Polymerase (PARP-1) Induces Release of the Pro-inflammatory Mediator HMGB1 from the NucleusJournal of Biological Chemistry, 2007
- Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2005
- Effects of Acute and Chronic Cyclophosphamide Treatment on Meiotic Progression and the Induction of DNA Double-Strand Breaks in Rat Spermatocytes1Biology of Reproduction, 2005
- Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell deathCell Death & Differentiation, 1999